128 related articles for article (PubMed ID: 37739265)
1. Adverse health outcomes and global quality of life in long-term testicular cancer survivors: a longitudinal 30-year perspective.
Fosså SD; Haugnes HS; Dahl AA; Kiserud CE; Fosså A; Skalleberg J; Myklebust TÅ
Ann Oncol; 2023 Dec; 34(12):1165-1174. PubMed ID: 37739265
[TBL] [Abstract][Full Text] [Related]
2. Mortality and Second Cancer Incidence After Treatment for Testicular Cancer: Psychosocial Health and Lifestyle Are Modifiable Prognostic Factors.
Fosså SD; Dahl AA; Thorsen L; Hellesnes R; Kiserud CE; Tandstad T; Brydøy M; Haugnes HS; Myklebust TÅ
J Clin Oncol; 2022 Aug; 40(23):2588-2599. PubMed ID: 35380874
[TBL] [Abstract][Full Text] [Related]
3. Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy.
Fung C; Sesso HD; Williams AM; Kerns SL; Monahan P; Abu Zaid M; Feldman DR; Hamilton RJ; Vaughn DJ; Beard CJ; Kollmannsberger CK; Cook R; Althouse S; Ardeshir-Rouhani-Fard S; Lipshultz SE; Einhorn LH; Fossa SD; Travis LB;
J Clin Oncol; 2017 Apr; 35(11):1211-1222. PubMed ID: 28240972
[TBL] [Abstract][Full Text] [Related]
4. Risk of positive selection bias in longitudinal surveys among cancer survivors: Lessons learnt from the national Norwegian Testicular Cancer Survivor Study.
Fosså SD; Dahl AA; Myklebust TÅ; Kiserud CE; Nome R; Klepp OH; Brydøy M; Haugnes HS
Cancer Epidemiol; 2020 Aug; 67():101744. PubMed ID: 32652337
[TBL] [Abstract][Full Text] [Related]
5. Use of Medications for Treating Anxiety or Depression among Testicular Cancer Survivors: A Multi-Institutional Study.
ArdeshirRouhaniFard S; Dinh PC; Monahan PO; Fossa SD; Huddart R; Fung C; Song Y; Feldman DR; Hamilton RJ; Vaughn DJ; Martin NE; Kollmannsberger C; Einhorn L; Kroenke K; Travis LB
Cancer Epidemiol Biomarkers Prev; 2021 Jun; 30(6):1129-1138. PubMed ID: 33849970
[TBL] [Abstract][Full Text] [Related]
6. Cumulative Burden of Morbidity Among Testicular Cancer Survivors After Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study.
Kerns SL; Fung C; Monahan PO; Ardeshir-Rouhani-Fard S; Abu Zaid MI; Williams AM; Stump TE; Sesso HD; Feldman DR; Hamilton RJ; Vaughn DJ; Beard C; Huddart RA; Kim J; Kollmannsberger C; Sahasrabudhe DM; Cook R; Fossa SD; Einhorn LH; Travis LB;
J Clin Oncol; 2018 May; 36(15):1505-1512. PubMed ID: 29617189
[TBL] [Abstract][Full Text] [Related]
7. Relationship of Cisplatin-Related Adverse Health Outcomes With Disability and Unemployment Among Testicular Cancer Survivors.
Kerns SL; Fung C; Fossa SD; Dinh PC; Monahan P; Sesso HD; Frisina RD; Feldman DR; Hamilton RJ; Vaughn D; Martin N; Huddart R; Kollmannsberger C; Sahasrabudhe D; Ardeshir-Rouhani-Fard S; Einhorn L; Travis LB
JNCI Cancer Spectr; 2020 Aug; 4(4):pkaa022. PubMed ID: 32704617
[TBL] [Abstract][Full Text] [Related]
8. Thyroid hypofunction in aging testicular cancer survivors.
Nome RV; Småstuen MC; Fosså SD; Kiserud CE; Åsvold BO; Bjøro T
Acta Oncol; 2021 Nov; 60(11):1452-1458. PubMed ID: 34351829
[TBL] [Abstract][Full Text] [Related]
9. The personality trait of neuroticism is strongly associated with long-term morbidity in testicular cancer survivors.
Grov EK; Fosså SD; Bremnes RM; Dahl O; Klepp O; Wist E; Dahl AA
Acta Oncol; 2009; 48(6):842-9. PubMed ID: 19412812
[TBL] [Abstract][Full Text] [Related]
10. Adverse Health Outcomes and Associations with Self-Reported General Health in Childhood Lymphoma Survivors.
Johannsdottir IMR; Hamre H; Fosså SD; Loge JH; Drolsum L; Lund MB; Nordsletten L; Kiserud C
J Adolesc Young Adult Oncol; 2017 Sep; 6(3):470-476. PubMed ID: 28837384
[TBL] [Abstract][Full Text] [Related]
11. Impact of pain and adverse health outcomes on long-term US testicular cancer survivors.
Dinh PC; Monahan PO; Fosså SD; Sesso HD; Feldman DR; Dolan ME; Nevel K; Kincaid J; Vaughn DJ; Martin NE; Sanchez VA; Einhorn LH; Frisina R; Fung C; Kroenke K; Travis LB
J Natl Cancer Inst; 2024 Mar; 116(3):455-467. PubMed ID: 37966940
[TBL] [Abstract][Full Text] [Related]
12. A controlled study of risk factors for disease and current problems in long-term testicular cancer survivors.
Dahl CF; Haugnes HS; Bremnes R; Dahl O; Fosså SD; Klepp O; Wist E; Dahl AA
J Cancer Surviv; 2010 Sep; 4(3):256-65. PubMed ID: 20574815
[TBL] [Abstract][Full Text] [Related]
13. Adverse Health Outcomes in Relationship to Hypogonadism After Chemotherapy: A Multicenter Study of Testicular Cancer Survivors.
Abu Zaid M; Dinh PC; Monahan PO; Fung C; El-Charif O; Feldman DR; Hamilton RJ; Vaughn DJ; Beard CJ; Cook R; Althouse S; Ardeshir-Rouhani-Fard S; Sesso HD; Huddart R; Mushiroda T; Kubo M; Dolan ME; Einhorn LH; Fossa SD; Travis LB;
J Natl Compr Canc Netw; 2019 May; 17(5):459-468. PubMed ID: 31085753
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal kidney function outcome in aging testicular cancer survivors.
Nome RV; Cvancarova Småstuen M; Bjøro T; Kiserud CE; Fosså SD
Acta Oncol; 2020 Apr; 59(4):467-474. PubMed ID: 32043400
[No Abstract] [Full Text] [Related]
15. Predicting Cardiovascular Disease Among Testicular Cancer Survivors After Modern Cisplatin-based Chemotherapy: Application of the Framingham Risk Score.
Feldman DR; Ardeshir-Rouhani-Fard S; Monahan P; Sesso HD; Fung C; Williams AM; Hamilton RJ; Vaughn DJ; Beard CJ; Cook R; Zaid MA; Lipshultz SE; Einhorn LH; Oeffinger KC; Travis LB; Fossa SD;
Clin Genitourin Cancer; 2018 Aug; 16(4):e761-e769. PubMed ID: 29534941
[TBL] [Abstract][Full Text] [Related]
16. Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors.
Brydøy M; Oldenburg J; Klepp O; Bremnes RM; Wist EA; Wentzel-Larsen T; Hauge ER; Dahl O; Fosså SD
J Natl Cancer Inst; 2009 Dec; 101(24):1682-95. PubMed ID: 19940282
[TBL] [Abstract][Full Text] [Related]
17. Chronic cancer-related fatigue in long-term survivors of testicular cancer.
Orre IJ; Fosså SD; Murison R; Bremnes R; Dahl O; Klepp O; Loge JH; Wist E; Dahl AA
J Psychosom Res; 2008 Apr; 64(4):363-71. PubMed ID: 18374735
[TBL] [Abstract][Full Text] [Related]
18. Association between long-term neuro-toxicities in testicular cancer survivors and polymorphisms in glutathione-s-transferase-P1 and -M1, a retrospective cross sectional study.
Oldenburg J; Kraggerud SM; Brydøy M; Cvancarova M; Lothe RA; Fossa SD
J Transl Med; 2007 Dec; 5():70. PubMed ID: 18162130
[TBL] [Abstract][Full Text] [Related]
19. Chronic fatigue in 812 testicular cancer survivors during long-term follow-up: increasing prevalence and risk factors.
Sprauten M; Haugnes HS; Brydøy M; Kiserud C; Tandstad T; Bjøro T; Bjerner J; Cvancarova M; Fosså SD; Oldenburg J
Ann Oncol; 2015 Oct; 26(10):2133-40. PubMed ID: 26265167
[TBL] [Abstract][Full Text] [Related]
20. The association between self-reported physical activity and prevalence of depression and anxiety disorder in long-term survivors of testicular cancer and men in a general population sample.
Thorsen L; Nystad W; Stigum H; Dahl O; Klepp O; Bremnes RM; Wist E; Fosså SD
Support Care Cancer; 2005 Aug; 13(8):637-46. PubMed ID: 15756585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
